In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. HTLV tests are used for the detection of HTLV-1 and/or HTLV-II, retroviruses associated with, or suspected of causing aggressive adult T-cell lymphoma (ATL), HTLV-I-associated myelopathy, uveitis, Strongyloides stercoralis hyper-infection, neurological problems, chronic lung infections and some other diseases. GlobalData uses proprietary data and analytics to provide a comprehensive report on the human t-lymphotropic virus devices market, including market shares of different players within Sweden. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the human t-lymphotropic virus market in Sweden was F. Hoffmann-La Roche followed by Abbott Laboratories, DiaSorin, MP Biomedicals and Werfen Life Group SAU.
Tests covered in the HTLV testing market include EIA and NAAT testing reagents as well as antigens, clinical grade antibodies, controls, and calibration materials. The HTLV testing market includes the sub-segments HTLV Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests and Other HTLV Tests.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the human t-lymphotropic virus devices market within Sweden was expected to be over $0.4m in 2022.
For the latest complete market share analysis of human t-lymphotropic virus device market in Sweden, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.